Fangsheng Pharmaceutical (603998.SH): Traditional Chinese medicine innovative medicine blood nourishment, wind relief and pain relief granules obtained the “Drug Registration Certificate”

Zhitong Finance App News, Fangsheng Pharmaceutical (603998.SH) announced that on June 9, 2025, Guangdong Fangsheng Jianmeng Pharmaceutical Co., Ltd. (hereinafter referred to as “Jianmeng Pharmaceutical”), a wholly-owned subsidiary of the company, received the “Drug Registration Certificate” approved and issued by the State Drug Administration (hereinafter referred to as the “State Drug Administration”). The Chinese medicine innovative medicine blood nourishment and pain relief granules independently developed by the company have obtained a drug approval number and can be produced.

Blood nourish and relieve wind and pain relief granules are based on the addition and subtraction formula of “Shengjiao Soup,” a representative formula of Mr. Zhang Xichun, a famous modern Chinese medicine practitioner. It can nourish qi and nourish blood and relieve wind and pain.